Iicon: Infection Innovation Consortium
Overview
Iicon: Infection Innovation Consortium is a biotechnology company headquartered in Liverpool, United Kingdom, founded in 2020, with approximately 201 employees.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Iicon: Infection Innovation Consortium in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.